ea0064032 | Peptide receptor radionuclide therapy controls inappropriate calcitriol secretion in a pancreatic neuro-endocrine tumor | BES2019
Haemels M
, Delaunoit T
, Van Laere K
, Van Cutsem E
, Verslype C
, Bex M
, Deroose CM
A 57 years-old patient presented with back pain, general discomfort, polydipsia, polyuria, fatigue and recent weight loss of 10 kg. Biochemical evaluation showed hypercalcemia (2.85 mmol/l; normal: 2.152.55) with low PTH level (14,2 ng/L; normal 14.956.9 ng/l) excluding primary hyperparathyroidism. The most frequent cause of hypercalcemia with non-elevated PTH levels is an underlying malignancy1. CT-thorax-abdomen showed a pancreatic neuroendocrine tumor...